|
市場調查報告書
支架技術的進
Advances in Stent Technologies
|
支架技術的進 是由出版商Technical Insights, Inc.在2007年12月所出版的。
這份英文市場調查報告書價格從美金6000起跳。
本報告書內容包括：全球支架技術相關現況及未來動向、課題、各國技術創新動向等。內容綱要摘記如下：
第1章 實施概要
第2章 技術採用因素
- 技術及產界發展的刺激因素
- 技術及產業課題
- 現在及未來動向
第3章 DES領域的技術創新
- 琺瑯質支架上市成功：加拿大
- 針對單項長期病及複合病變的客製化可溶解性支架：美國
- 禧福可溶解性支架：美國
- 為降低再狭窄率的新複合藥物設備併用：日本
- 為了介入的高分子陣列：德國
- 獨特設計及活體安全性小分子的支架構造：西班牙
- 低投藥量藥劑釋出動力學有助於降低血栓率
- 退黑激素釋出支架：荷蘭
- 低投藥量紫杉醇支架評分：德國
第4章 專利及主要聯絡對象
第5章 決策支援資料庫
Abstract
This Frost & Sullivan research service titled Advances in Stent Technologies
provides the reader with an overview of the drug eluting stent industry, talks
about the present day challenges alongside the drivers that drive the growth
of the DES business. In addition, it provides readers with packets of
information on emerging technologies in the DES space and the new
bioabsorbable stent, which is set to revolutionize the stent business. In this
research, Frost & Sullivan' s expert analysts thoroughly examine the following
stent technologies: drug eluting, and bioabsorbable.
This analysis is available through our Technical Insights Growth Partnership
Service program. With this program, clients receive industry-leading market
research such as this, along with technical and econometric data and many
interactive features including Analyst Inquiry Time and Client Councils.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Scope of the Research Service
- Methodology
- Stents--Overview and Classification
- Evolution of Drug Eluting and Bioabsorbable Stents
- Noteworthy Technological Innovations--A Gist
2 TECHNOLOGY ADOPTION FACTORS
- Technology-Related Drivers and Challenges
- Drivers for the Technology and the Industry
- Technology and Industry-Related Challenges
- Current and Future Trends
- A Basic SWOT Analysis; Analyst Perceptions and Insights
- DES Technology--A Basic SWOT Analysis
- Analyst Perceptions and Insights
3 INNOVATIONS IN DES SPACE
- DES Innovations--USA and Canada
- Successful Launch of Hydroxyapatite-Based Stents--Canada
- Customizable Biodegradable Stents for Single Long and Multiple
Lesions--USA
- Sirolimus-Based Biodegradable Stents--USA
- DES Innovations--Europe and Other Countries
- New Hybrid Drug Device Combination to Lower Restenosis Rates--Japan
- Polymer-Free Matrices to the Rescue of Interventionalists--Germany
- A Stent Structure with an Unique Design and a Biostable Polymer--Spain
- Low-Dose Drug Release Kinetics Helps Lower Thrombosis Rates--South Africa
- Melatonin-Based Drug Eluting Stents--Netherlands
- Low-Dose Paclitaxel-Based Stent Scores over First Generation DES--Germany
4 PATENT INFORMATION AND KEY CONTACTS
- Patents in US and Europe
- US and Canada Patents
- Patents in Europe and Rest of the World
- Key Contacts and Glossary
- Key Contacts--Industry and Academia
- Glossary
5 DECISION SUPPORT DATABASE
- Database Tables
- Total Healthcare Expenditure--World (2002 to 2012)
- Total Number of Hospitals--World (2002 to 2012)
- Total Number of Physicians--World (2002 to 2012)
- Incidence of Myocardial Infarction (Heart Attack) (2002 to 2012)
- Prevalence of Chronic Obstructive Pulmonary Disease (COPD) (2002 to 2012)
|
